Compounds and compositions for targeting macrophages and other mannose-binding c-type lectin receptor high expressing cells and methods of treating and diagnosis using same
US-2022211680-A1 · Jul 7, 2022 · US
This page is not indexed by search engines while we improve data quality.
Cardinal Health 414 Llc patents
Cardinal Health 414 Llc holds 3 patents in our database, with recent filings and technology areas summarized below.
| Metric | Value |
|---|---|
| Total patents | 3 |
| Recent patents | 0 |
| First publication | Oct 20, 2020 |
| Latest publication | Jul 7, 2022 |
Filing trend
Year-over-year patent counts for this assignee.
Recent patents
Latest publications where this party is an assignee.
Notable patents
Representative or frequently cited publications from precomputed assignee stats.
Compounds and compositions for targeting macrophages and other mannose-binding c-type lectin receptor high expressing cells and methods of treating and diagnosis using same
US-2022211680-A1 · Jul 7, 2022 · US
Compositions, methods and kits for diagnosing and treating cd206 expressing cell-related disorders
US-2022016272-A1 · Jan 20, 2022 · US
Compositions for targeting macrophages and other CD206 high expressing cells and methods of treating and diagnosis
US-10806803-B2 · Oct 20, 2020 · US
Technology areas
Mapped technology topics for this assignee.
| Technology | Patents |
|---|---|
| Human Necessities | 3 |
| Chemistry & Metallurgy | 2 |
| Physics | 1 |
| Cross-Sectional Technologies | 1 |